Pruritus News and Research

RSS
Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

FDA grants accelerated approval to new treatment for children with Chagas disease

FDA grants accelerated approval to new treatment for children with Chagas disease

FDA grants accelerated approval to cancer treatment based on common biomarker

FDA grants accelerated approval to cancer treatment based on common biomarker

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Dr Anjali Mahto explains how to prevent risk of mosquito bites

Dr Anjali Mahto explains how to prevent risk of mosquito bites

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

VIEKIRAX and EXVIERA achieve high SVR rates in GT1 and GT4 hepatitis C virus infected patients

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings